TRAVERSA SERGIO
Insider CIK 1565832 · ATNM Interim CFO, Director · RLMD Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2026-09-10 | 2026-09-11 | 100,000 | $4.10 | $410.0K | 1,500,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2026-09-10 | 2026-09-11 | 100,000 | $4.10 | $410.0K | 1,500,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2026-09-09 | 2026-09-11 | 100,000 | $4.18 | $418.0K | 1,400,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2026-09-09 | 2026-09-11 | 100,000 | $4.18 | $418.0K | 1,400,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-12-15 | 2025-12-16 | 27,500 | $4.12 | $113.3K | 1,300,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,198,000 | — | $0 | 1,198,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-11-05 | 2025-11-06 | 272,500 | $2.20 | $599.5K | 1,272,500 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-08-28 | 2025-08-28 | 55,976 | $0.74 | $41.4K | 1,000,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-08-27 | 2025-08-28 | 129,455 | $0.67 | $86.7K | 944,024 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-08-26 | 2025-08-28 | 80,545 | $0.62 | $49.9K | 814,569 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2025-06-26 | 2025-06-30 | 800,000 | — | $0 | 800,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-05-20 | 2025-05-20 | 147,686 | $0.56 | $82.7K | 734,024 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-05-19 | 2025-05-20 | 30,000 | $0.50 | $15.0K | 586,338 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-05-16 | 2025-05-20 | 172,314 | $0.45 | $77.5K | 556,338 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-09-11 | 2024-09-11 | 51,407 | $2.99 | $153.7K | 384,024 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-09-10 | 2024-09-11 | 33,014 | $2.75 | $90.8K | 332,617 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-09-09 | 2024-09-11 | 55,579 | $2.71 | $150.6K | 299,603 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2024-05-24 | 2024-05-29 | 122,358 | — | $0 | 306,239 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | J Other deriv | 2024-05-24 | 2024-05-29 | 122,358 | — | $0 | 183,881 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-01-31 | 2024-01-31 | 27,460 | $4.00 | $109.8K | 244,024 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-01-30 | 2024-01-31 | 40,999 | $3.90 | $159.9K | 216,564 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-01-29 | 2024-01-31 | 31,541 | $3.71 | $117.0K | 175,565 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2023-12-15 | 2023-12-19 | 183,881 | — | $0 | 183,881 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2023-05-25 | 2023-05-30 | 527,211 | — | $0 | 850,728 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-12-16 | 2022-12-20 | 323,517 | — | $0 | 323,517 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | J Other deriv | 2022-12-16 | 2022-12-20 | 300,000 | — | $0 | 0 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2022-12-08 | 2022-12-12 | 55,250 | $2.10 | $116.0K | 144,024 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2022-07-01 | 2022-07-05 | 13,755 | — | $0 | 0 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-07-01 | 2022-07-05 | 839 | $18.48 | $15.5K | 101,690 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-07-01 | 2022-07-05 | 8,848 | $18.45 | $163.2K | 92,842 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-07-01 | 2022-07-05 | 4,068 | $18.32 | $74.5K | 88,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2022-07-01 | 2022-07-05 | 13,755 | $16.00 | $220.1K | 102,529 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2022-06-30 | 2022-07-05 | 16,012 | — | $0 | 13,755 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2022-06-30 | 2022-07-05 | 16,012 | $16.00 | $256.2K | 104,786 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-06-30 | 2022-07-05 | 5,314 | $19.37 | $102.9K | 99,472 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-06-30 | 2022-07-05 | 10,698 | $19.01 | $203.4K | 88,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-05-25 | 2022-05-26 | 651,821 | — | $0 | 1,143,994 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-05-25 | 2022-05-26 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-12-17 | 2021-12-21 | 492,173 | — | $0 | 492,173 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-03-10 | 2021-03-11 | 2,983 | $35.09 | $104.7K | 88,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-03-09 | 2021-03-11 | 10,000 | — | $0 | 99,211 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-03-09 | 2021-03-11 | 5,217 | $35.42 | $184.8K | 93,937 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-03-09 | 2021-03-11 | 1,800 | $36.32 | $65.4K | 91,757 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-03-09 | 2021-03-11 | 10,000 | $3.24 | $32.4K | 98,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-24 | 2021-02-26 | 10,000 | — | $0 | 109,211 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-24 | 2021-02-26 | 4,837 | $33.69 | $163.0K | 93,937 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-24 | 2021-02-26 | 10,000 | $3.24 | $32.4K | 98,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-24 | 2021-02-26 | 303 | $35.55 | $10.8K | 88,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-24 | 2021-02-26 | 4,860 | $34.70 | $168.6K | 89,077 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-11 | 2021-02-16 | 1,446 | — | $0 | 119,211 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-11 | 2021-02-16 | 1,446 | $35.43 | $51.2K | 88,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-11 | 2021-02-16 | 1,446 | $3.24 | $4.7K | 90,220 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-10 | 2021-02-10 | 1,930 | $35.28 | $68.1K | 88,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-09 | 2021-02-10 | 5,963 | $35.21 | $210.0K | 90,704 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-08 | 2021-02-10 | 11,206 | — | $0 | 120,657 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-08 | 2021-02-10 | 11,206 | $3.24 | $36.3K | 99,980 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-08 | 2021-02-10 | 3,313 | $35.03 | $116.1K | 96,667 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-03 | 2021-02-04 | 100 | $35.00 | $3.5K | 88,874 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-02 | 2021-02-04 | 3,278 | — | $0 | 145,144 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-02 | 2021-02-04 | 13,281 | — | $0 | 131,863 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-02 | 2021-02-04 | 3,178 | $35.08 | $111.5K | 88,874 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-02 | 2021-02-04 | 3,278 | $3.24 | $10.6K | 92,052 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-02 | 2021-02-04 | 13,281 | $3.24 | $43.0K | 88,774 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-01-27 | 2021-01-29 | 10,000 | — | $0 | 148,422 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-01-27 | 2021-01-29 | 10,000 | $3.24 | $32.4K | 85,493 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-27 | 2021-01-29 | 100 | $33.43 | $3.3K | 75,493 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-27 | 2021-01-29 | 4,351 | $31.77 | $138.2K | 81,142 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-27 | 2021-01-29 | 5,549 | $32.86 | $182.3K | 75,593 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-26 | 2021-01-26 | 600 | $35.15 | $21.1K | 75,493 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-25 | 2021-01-26 | 1,300 | $35.29 | $45.9K | 76,093 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-01-22 | 2021-01-26 | 4,070 | — | $0 | 158,422 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-01-22 | 2021-01-26 | 4,070 | $3.24 | $13.2K | 79,563 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-22 | 2021-01-26 | 1,736 | $35.44 | $61.5K | 77,827 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-22 | 2021-01-26 | 434 | $36.15 | $15.7K | 77,393 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-01-07 | 2021-01-11 | 250,000 | — | $0 | 250,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-01-07 | 2021-01-11 | 250,000 | — | $0 | 250,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2020-08-18 | 2020-08-19 | 50,008 | — | $0 | 162,492 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2020-08-18 | 2020-08-19 | 50,008 | $3.24 | $162.0K | 79,644 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | F Tax w/h | 2020-08-18 | 2020-08-19 | 4,151 | $39.03 | $162.0K | 75,493 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2019-12-19 | 2019-12-23 | 350,000 | $43.47 | $15.21M | 350,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2019-07-29 | 2019-07-30 | 1,700,000 | $2.20 | $3.74M | 1,700,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2018-12-20 | 2018-12-20 | 900,000 | $1.15 | $1.03M | 900,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2017-10-19 | 2017-10-23 | 850,000 | $0.81 | $688.5K | 850,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2017-03-14 | 2017-03-16 | 75,000 | $1.39 | $104.2K | 75,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2016-04-15 | 2016-04-18 | 75,000 | $1.99 | $149.3K | 75,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2016-04-15 | 2016-04-18 | 1,000 | $2.02 | $2.0K | 3,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2016-04-14 | 2016-04-18 | 2,000 | $2.02 | $4.0K | 2,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 2,759 | $2.99 | $8.2K | 323,352 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 241 | $2.92 | $704 | 320,593 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 1,800 | $3.42 | $6.2K | 339,322 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 200 | $3.34 | $668 | 337,522 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 42 | $3.39 | $142 | 337,322 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 2,370 | $2.98 | $7.1K | 325,722 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 4,358 | $3.00 | $13.1K | 335,680 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 1,600 | $3.40 | $5.4K | 337,280 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 5,600 | $2.91 | $16.3K | 331,322 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-14 | 2015-12-16 | 30 | $2.97 | $89 | 320,352 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2015-02-23 | 2015-03-05 | 225,000 | $2.70 | $607.5K | 872,745 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2015-02-18 | 2015-03-16 | 25,000 | $3.58 | $89.5K | 25,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2013-08-08 | 2013-12-24 | 20,000 | $3.60 | $72.0K | 4,995 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2013-08-08 | 2013-12-24 | 10,000 | $3.60 | $36.0K | 0 | SEC↗ |